Your browser is no longer supported. Please, upgrade your browser.
QGEN QIAGEN N.V. monthly Stock Chart
QGEN [NYSE]
QIAGEN N.V.
Index- P/E- EPS (ttm)-0.15 Insider Own3.60% Shs Outstand232.21M Perf Week4.31%
Market Cap10.33B Forward P/E25.89 EPS next Y1.72 Insider Trans0.00% Shs Float227.06M Perf Month1.25%
Income-31.10M PEG- EPS next Q0.40 Inst Own80.20% Short Float1.49% Perf Quarter12.81%
Sales1.55B P/S6.67 EPS this Y-122.40% Inst Trans8.00% Short Ratio3.15 Perf Half Y32.27%
Book/sh10.73 P/B4.15 EPS next Y6.23% ROA-0.60% Target Price38.91 Perf Year11.43%
Cash/sh3.21 P/C13.87 EPS next 5Y9.43% ROE-1.20% 52W Range25.04 - 44.41 Perf YTD31.80%
Dividend- P/FCF55.10 EPS past 5Y-18.80% ROI0.40% 52W High0.32% Beta0.30
Dividend %- Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.10% 52W Low77.92% ATR0.59
Employees5096 Current Ratio1.60 Sales Q/Q6.70% Oper. Margin0.30% RSI (14)65.79 Volatility1.22% 1.36%
OptionableYes Debt/Eq0.69 EPS Q/Q35.70% Profit Margin-2.00% Rel Volume1.07 Prev Close43.57
ShortableYes LT Debt/Eq0.56 EarningsAug 04 AMC Payout- Avg Volume1.07M Price44.55
Recom2.80 SMA203.62% SMA503.87% SMA20017.24% Volume1,145,810 Change2.25%
Mar-04-20Downgrade Berenberg Buy → Hold
Jan-08-20Initiated Wells Fargo Equal Weight $36
Jan-07-20Initiated Citigroup Neutral $35
Dec-26-19Resumed BofA/Merrill Underperform $28
Nov-15-19Initiated Stifel Hold
Nov-14-19Upgrade Kepler Reduce → Hold
Nov-14-19Upgrade JP Morgan Underweight → Overweight
Nov-14-19Upgrade Evercore ISI In-line → Outperform
Oct-17-19Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19Downgrade Kepler Hold → Reduce
Oct-08-19Downgrade JP Morgan Neutral → Underweight
Oct-08-19Downgrade Deutsche Bank Buy → Hold
Oct-08-19Downgrade Barclays Overweight → Equal Weight
Jul-16-19Downgrade Evercore ISI Outperform → In-line
Jul-12-19Upgrade Exane BNP Paribas Neutral → Outperform
May-30-19Initiated Wolfe Research Peer Perform
Mar-15-19Initiated UBS Neutral
Jan-29-18Initiated Goldman Buy $39
Nov-03-16Upgrade BofA/Merrill Underperform → Neutral
Aug-01-16Upgrade HSBC Securities Hold → Buy
Jul-08-20 08:48AM  
Jul-07-20 10:24AM  
Jul-03-20 12:38PM  
09:39AM  
08:30AM  
Jul-02-20 08:46AM  
08:11AM  
Jul-01-20 09:45AM  
Jun-30-20 01:55PM  
10:40AM  
Jun-29-20 09:44AM  
Jun-24-20 09:50AM  
Jun-23-20 11:37AM  
07:19AM  
Jun-22-20 04:05PM  
11:22AM  
Jun-18-20 11:30PM  
11:06AM  
Jun-15-20 10:49AM  
Jun-11-20 11:16AM  
Jun-09-20 04:42PM  
10:23AM  
10:05AM  
Jun-08-20 10:22AM  
Jun-05-20 11:31AM  
09:47AM  
Jun-04-20 09:03AM  
Jun-01-20 10:22AM  
09:59AM  
May-29-20 10:31AM  
May-28-20 04:05PM  
11:40AM  
11:34AM  
May-26-20 09:06AM  
May-20-20 07:15PM  
May-18-20 03:34PM  
07:00AM  
03:18AM  
03:15AM  
May-14-20 10:58PM  
May-12-20 12:20PM  
May-07-20 10:40AM  
07:02AM  
May-06-20 04:05PM  
08:42AM  
May-05-20 04:55PM  
May-03-20 05:22PM  
Apr-30-20 10:39AM  
09:00AM  
Apr-23-20 07:52AM  
Apr-22-20 06:15AM  
Apr-20-20 10:57PM  
Apr-17-20 10:59AM  
08:43AM  
Apr-15-20 04:05PM  
09:33AM  
Apr-14-20 03:52PM  
Apr-10-20 11:40AM  
Apr-09-20 12:30PM  
Apr-07-20 09:00AM  
Apr-02-20 02:55PM  
09:16AM  
Apr-01-20 11:00AM  
Mar-31-20 05:10PM  
10:03AM  
04:05AM  
Mar-30-20 05:06PM  
12:18PM  
09:34AM  
Mar-27-20 10:37AM  
Mar-26-20 06:19PM  
03:30PM  
Mar-24-20 02:11PM  
01:00PM  
08:20AM  
07:43AM  
05:47AM  
05:47AM  
05:30AM  
Mar-23-20 09:48PM  
04:21PM  
Mar-21-20 06:14PM  
Mar-20-20 09:35AM  
Mar-19-20 02:00PM  
09:12AM  
08:30AM  
Mar-18-20 07:00PM  
09:51AM  
07:36AM  
Mar-17-20 04:09PM  
03:39PM  
11:30AM  
Mar-16-20 12:19PM  
09:59AM  
Mar-13-20 09:01AM  
Mar-12-20 12:15PM  
Mar-11-20 07:26PM  
03:39PM  
Mar-10-20 05:18PM  
01:52PM  
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. It serves molecular diagnostics, applied testing, pharma, and academia customers. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.